These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1809 related articles for article (PubMed ID: 27915972)

  • 21. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
    Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
    Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.
    Bourguignon LYW; Earle C; Shiina M
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Novel Small-molecule WNT Inhibitor, IC-2, Has the Potential to Suppress Liver Cancer Stem Cells.
    Seto K; Sakabe T; Itaba N; Azumi J; Oka H; Morimoto M; Umekita Y; Shiota G
    Anticancer Res; 2017 Jul; 37(7):3569-3579. PubMed ID: 28668848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural Cyclophilin A Inhibitors Suppress the Growth of Cancer Stem Cells in Non-Small Cell Lung Cancer by Disrupting Crosstalk between CypA/CD147 and EGFR.
    Han JM; Kim SM; Kim HL; Cho HJ; Jung HJ
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Roles of Cancer Stem Cells and Therapy Resistance in Colorectal Carcinoma.
    Das PK; Islam F; Lam AK
    Cells; 2020 Jun; 9(6):. PubMed ID: 32503256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resistance of lung cancer.
    Yeh CT; Wu AT; Chang PM; Chen KY; Yang CN; Yang SC; Ho CC; Chen CC; Kuo YL; Lee PY; Liu YW; Yen CC; Hsiao M; Lu PJ; Lai JM; Wang LS; Wu CH; Chiou JF; Yang PC; Huang CY
    Am J Respir Crit Care Med; 2012 Dec; 186(11):1180-8. PubMed ID: 23024022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer stem cell (CSC) resistance drivers.
    Najafi M; Mortezaee K; Majidpoor J
    Life Sci; 2019 Oct; 234():116781. PubMed ID: 31430455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concise Review: Targeting Cancer Stem Cells Using Immunologic Approaches.
    Pan Q; Li Q; Liu S; Ning N; Zhang X; Xu Y; Chang AE; Wicha MS
    Stem Cells; 2015 Jul; 33(7):2085-92. PubMed ID: 25873269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer stem cells and their potential implications for the treatment of solid tumors.
    Grotenhuis BA; Wijnhoven BP; van Lanschot JJ
    J Surg Oncol; 2012 Aug; 106(2):209-15. PubMed ID: 22371125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An alginate-based platform for cancer stem cell research.
    Qiao SP; Zhao YF; Li CF; Yin YB; Meng QY; Lin FH; Liu Y; Hou XL; Guo K; Chen XB; Tian WM
    Acta Biomater; 2016 Jun; 37():83-92. PubMed ID: 27109764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elucidation of Altered Pathways in Tumor-Initiating Cells of Triple-Negative Breast Cancer: A Useful Cell Model System for Drug Screening.
    Christensen AG; Ehmsen S; Terp MG; Batra R; Alcaraz N; Baumbach J; Noer JB; Moreira J; Leth-Larsen R; Larsen MR; Ditzel HJ
    Stem Cells; 2017 Aug; 35(8):1898-1912. PubMed ID: 28600813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic approaches targeting cancer stem cells.
    Pan Y; Ma S; Cao K; Zhou S; Zhao A; Li M; Qian F; Zhu C
    J Cancer Res Ther; 2018; 14(7):1469-1475. PubMed ID: 30589025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eliminating Cancer Stem-Like Cells in Oral Cancer by Targeting Elementary Signaling Pathways.
    Joshi J; Patel H; Bhavnagari H; Tarapara B; Pandit A; Shah F
    Crit Rev Oncog; 2022; 27(4):65-82. PubMed ID: 37199303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual-Blocking of PI3K and mTOR Improves Chemotherapeutic Effects on SW620 Human Colorectal Cancer Stem Cells by Inducing Differentiation.
    Kim MJ; Koo JE; Han GY; Kim B; Lee YS; Ahn C; Kim CW
    J Korean Med Sci; 2016 Mar; 31(3):360-70. PubMed ID: 26955235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic potential of cancer stem cells.
    Yang C; Jin K; Tong Y; Cho WC
    Med Oncol; 2015 Jun; 32(6):619. PubMed ID: 25920610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New emerging roles of CD133 in cancer stem cell: Signaling pathway and miRNA regulation.
    Aghajani M; Mansoori B; Mohammadi A; Asadzadeh Z; Baradaran B
    J Cell Physiol; 2019 Dec; 234(12):21642-21661. PubMed ID: 31102292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer cells stemness: A doorstep to targeted therapy.
    Prasad S; Ramachandran S; Gupta N; Kaushik I; Srivastava SK
    Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165424. PubMed ID: 30818002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer stem cells (CSCs), cervical CSCs and targeted therapies.
    Huang R; Rofstad EK
    Oncotarget; 2017 May; 8(21):35351-35367. PubMed ID: 27343550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glioblastoma Multiforme Stem Cell Cycle Arrest by Alkylaminophenol Through the Modulation of EGFR and CSC Signaling Pathways.
    Doan P; Musa A; Murugesan A; Sipilä V; Candeias NR; Emmert-Streib F; Ruusuvuori P; Granberg K; Yli-Harja O; Kandhavelu M
    Cells; 2020 Mar; 9(3):. PubMed ID: 32164385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting.
    Eun K; Ham SW; Kim H
    BMB Rep; 2017 Mar; 50(3):117-125. PubMed ID: 27998397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 91.